Promab develops and commercializes recombinant proteins and antibodies through the integration of bioinformatics, gene cloning and immunology... Read more
Promab develops and commercializes recombinant proteins and antibodies through the integration of bioinformatics, gene cloning and immunology... Read more
News
Jul 27, 2020
Drug Genius
ProMab: ProMab Presents Promising Results in Humanized CD19 CAR-T Cells Trial
Feb 19, 2020
BioPortfolio
ProMab Biotechnologies: Caribou Biosciences and ProMab Biotechnologies Announce Sale and Assignment Agreement for Humanized scFv Targeting BCMA
Feb 19, 2020
FirstWord Pharma
ProMab Biotechnologies: Caribou Biosciences and ProMab Biotechnologies Announce Sale and Assignment Agreement for Humanized scFv Targeting BCMA
Mar 05, 2019
Pharamceutical Technology
Promab: NantKwest and ProMab partner to develop NK cell therapies
Mar 04, 2019
4-traders
Promab: NantKwest : Signs Worldwide License Agreement with ProMab Biotechnologies to Exclusively�Develop Select Next Generation Targeted Natural Killer Cell Therapeutics
Mar 04, 2019
pipelinereview
Promab: NantKwest Signs Worldwide License Agreement with ProMab Biotechnologies to Exclusively Develop Select Next Generation Targeted Natural Killer Cell Therapeutics
Jul 11, 2018
Promab Youtube Channel
Promab posted a video "Engineered Cytotoxic CAR-T cells with Decreased Cytokine Secretion" on YOUTUBE
Jan 04, 2018
Marketwired
Press Release: Promab : Helix Biopharma Corp. Signs Binding Letter of Intent for Development of New CAR-T Technologies
Dec 05, 2017
SpaceGab
Promab: ProMab Biotechnologies Acquires One World Lab
Feb 15, 2017
BioPortfolio
Promab: Cryoport to support ProMab biotechnologies CART cell preclinical services
ProMab Competitors
1
2
3
4
5
6
7
8
9
10